Printer Friendly

BARR LABORATORIES NOTIFIED OF DECISION IN BREACH OF CONTRACT CASE

 BARR LABORATORIES NOTIFIED OF DECISION IN BREACH OF CONTRACT CASE
 POMONA, N.Y., Nov. 20 /PRNewswire/ -- Barr Laboratories, Inc. (AMEX: BRL), today announced it received notification of the decision in a breach of contract case tried in 1989.
 As of June 30, 1990, the company had reserved $2.5 million for this litigation. It will therefore be necessary for the company to provide an additional $1 million during the quarter ended Dec. 31, 1991.
 The company intends to appeal this judgment.
 -0- 11/20/91
 /CONTACT: Louis J. Guerci, vice president-finance of Barr Laboratories, 914-362-1100/
 (BRL) CO: Barr Laboratories, Inc. ST: New York IN: MTC SU:


GK -- NY013 -- 5272 11/20/91 09:06 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 20, 1991
Words:115
Previous Article:AMDL ANNOUNCES LETTER OF INTENT FROM L.P. CHARLES AND CO.
Next Article:WICAT ANNOUNCES $1.9 MILLION AGREEMENT WITH SIKORSKY AIRCRAFT


Related Articles
CONSUMER ALERT: DRUG RECALL
BARR LABORATORIES ANNOUNCES ADDITIONAL ASSESSMENT
BARR ANNOUNCES SECOND QUARTER SALES AND EARNINGS
BARR NAMES NEW PRESIDENT AND CHIEF OPERATING OFFICER
JUDGE CLEARS WAY FOR AZT TRIAL TO BEGIN JUNE 28
BARR LABORATORIES, FDA SETTLE 1992 COURT CASE; COURT'S ORDER ESTABLISHES PROCESS FOR COMPANY TO REINTRODUCE FORMER PRODUCTS
Barr Prozac Challenge to Proceed on Grounds of Inequitable Conduct; Company Disappointed with Judge's Decision Dismissing Additional Claims.
Barr to Take Prozac Challenge Directly to Court of Appeals Defendants Agree to Drop Inequitable Conduct and Anticipation Claims.
Barr Initiates Challenge of Raw Material Patents on Tambocor(TM) Heart Drug.
Ranbaxy Files Suit Against Barr Laboratories and Teva Pharmaceuticals USA.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters